EHA 2017 | UKALL60+: identifying the standard of care for elderly patients with ALL

Name: UKALL60+: identifying the standard of care for elderly patients with ALL
Uploaded: 2017-06-24T09:59:24.000Z
Duration: 53 s
Description: UKALL60+ is a trial for acute lymphoblastic leukemia (ALL) that aims to identify a standard of care for patients over the age of 60 yrs. David Marks, MD, PhD, from the University Hospitals Bristol NHS Foundation Trust, Bristol, UK, talks to us about the aims of the trial. Recorded at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.

David Marks • 24 Jun 2017

EHA 2017

Acute Lymphoblastic Leukemia

UKALL60+

UKALL60+ is a trial for acute lymphoblastic leukemia (ALL) that aims to identify a standard of care for patients over the age of 60 yrs. David Marks, MD, PhD, from the University Hospitals Bristol NHS Foundation Trust, Bristol, UK, talks to us about the aims of the trial. Recorded at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.